Login to your account

Username *
Password *
Remember Me
Bibliographie

Bibliographie (2530)

ATS Guideline: Nucleic acid–based testing for noninfluenza viral pathogens in adults with suspected community-acquired pneumonia – Testing should be considered only in patients with severe CAP and in immunocompromised patients

mercredi, 05 mai 2021 14:40 Écrit par

Nucleic Acid–based Testing for Noninfluenza Viral Pathogens in Adults with Suspected Community-acquired Pneumonia. An Official American Thoracic Society Clinical Practice Guideline News Release: New clinical practice guideline on community acquired pneumonia – American Thoracic Society  

The post ATS Guideline: Nucleic acid–based testing for noninfluenza viral pathogens in adults with suspected community-acquired pneumonia – Testing should be considered only in patients with severe CAP and in immunocompromised patients appeared first on Links Medicus.

Perspective | We may never achieve long-term global herd immunity for COVID. But if we’re all vaccinated, we’ll be safe from the worst

mercredi, 05 mai 2021 14:40 Écrit par

We may never achieve long-term global herd immunity for COVID. But if we’re all vaccinated, we’ll be safe from the worst – The Conversation See also: Reaching ‘Herd Immunity’ Is Unlikely in the U.S., Experts Now Believe – The New York Times (free registration required) AND We May Never Get to Herd Immunity – Think Global Health  

The post Perspective | We may never achieve long-term global herd immunity for COVID. But if we’re all vaccinated, we’ll be safe from the worst appeared first on Links Medicus.

What’s the future of vaccines linked to rare clotting disorders? Science breaks down the latest

mercredi, 05 mai 2021 14:40 Écrit par

What’s the future of vaccines linked to rare clotting disorders? Science breaks down the latest – Science  

The post What’s the future of vaccines linked to rare clotting disorders? Science breaks down the latest appeared first on Links Medicus.

[Preprint] SARS-CoV-2 antibodies remain detectable 12 months after infection and antibody magnitude is associated with age and COVID-19 severity

mercredi, 05 mai 2021 14:40 Écrit par

SARS-CoV-2 antibodies remain detectable 12 months after infection and antibody magnitude is associated with age and COVID-19 severity – medRxiv Commentary: SARS-CoV-2 antibodies are detectable up to a year after infection, finds study – News Medical   Commentary on Twitter Ahhh… A year has passed since people with Covid-19 were enrolled in a longitudinal study […]

The post [Preprint] SARS-CoV-2 antibodies remain detectable 12 months after infection and antibody magnitude is associated with age and COVID-19 severity appeared first on Links Medicus.

Novel coronavirus really is seasonal, study suggests

mardi, 04 mai 2021 14:13 Écrit par

Novel coronavirus really is seasonal, study suggests – LiveScience Original study: Climate and the spread of COVID-19 – Scientific Reports  

The post Novel coronavirus really is seasonal, study suggests appeared first on Links Medicus.

Prior SARS-CoV-2 infection boosts response to variants after first vaccine dose

mardi, 04 mai 2021 14:13 Écrit par

Prior SARS-CoV-2 infection boosts response to variants after first vaccine dose – Imperial College London Original study: Prior SARS-CoV-2 infection rescues B and T cell responses to variants after first vaccine dose – Science   Commentary on Twitter (thread – click for more) Just published @ScienceMagazine "After one dose, individuals with *prior infection* showed enhanced […]

The post Prior SARS-CoV-2 infection boosts response to variants after first vaccine dose appeared first on Links Medicus.

Case series of 12 patients with cerebral venous sinus thrombosis with thrombocytopenia after Ad26.COV2.S vaccination – all women younger than 60 years, with symptoms from 6 to 15 days after vaccination

lundi, 03 mai 2021 10:38 Écrit par

US Case Reports of Cerebral Venous Sinus Thrombosis With Thrombocytopenia After Ad26.COV2.S Vaccination, March 2 to April 21, 2021 – JAMA Editorial: Assessing a Rare and Serious Adverse Event Following Administration of the Ad26.COV2.S Vaccine – JAMA See also: Safety Monitoring of the Janssen (Johnson & Johnson) COVID-19 Vaccine — United States, March–April 2021 – […]

The post Case series of 12 patients with cerebral venous sinus thrombosis with thrombocytopenia after Ad26.COV2.S vaccination – all women younger than 60 years, with symptoms from 6 to 15 days after vaccination appeared first on Links Medicus.